Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May;272(5):1061-77.
doi: 10.1007/s00405-014-3065-8. Epub 2014 May 7.

Lipomatous tumours of the head and neck: a spectrum of biological behaviour

Affiliations
Review

Lipomatous tumours of the head and neck: a spectrum of biological behaviour

Eelco de Bree et al. Eur Arch Otorhinolaryngol. 2015 May.

Abstract

Lipomatous tumours are rare in the head and neck region. Their biological behaviour varies greatly, from absolutely benign to histologically benign but locally infiltrative and, finally, invasive with metastatic potential. Each lipomatous tumour has to be treated accordingly. It is of paramount importance before eventual surgery is planned to perform adequate imaging, diagnostic biopsy and careful assessment. Only in small (<5 cm), superficial soft tissue tumours or when magnetic resonance imaging has demonstrated specific features of lipoma, may diagnostic biopsy be omitted. In these cases, expectant management or simple excision is appropriate. Adequate preoperative diagnosis is important to assure adequate tumour control as well as optimal functional and cosmetic outcome. The major problem in the treatment of lipomatous tumours of the head and neck region is the presence of nearby delicate structures. Especially, wide surgical excision of liposarcomas may be hindered by anatomic constraints and may result in impaired functional and cosmetic outcome. Neoadjuvant radiotherapy and specific systemic chemotherapy may be helpful in the treatment of liposarcoma, especially when unresectable or when primary surgery is expected to result in poor oncological, functional or cosmetic outcome. Greater emphasis placed on the underlying biology of individual sarcoma subtypes, development and evaluation of novel therapies and greater specificity in the selection of chemotherapy agents based on activity in individual histological subtypes are expected to lead to improved efficacy of systemic treatment.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Bone Joint Surg Am. 1996 May;78(5):656-63 - PubMed
    1. Arch Pathol Lab Med. 2006 Jul;130(7):1049-52 - PubMed
    1. Cancer. 2008 Aug 1;113(3):573-81 - PubMed
    1. Otolaryngol Head Neck Surg. 2012 Mar;146(3):512-3 - PubMed
    1. J Pediatr Surg. 2001 Jan;36(1):229-31 - PubMed

LinkOut - more resources